Infusion Partners

Form 483 issued September 25, 2018 · Sharpsburg, Pennsylvania

Inspection
Sep 25, 2018
Investigator
Marcus A. Ray
Observations
2
Pages
1
FEI number
3011127887

In short: On September 25, 2018, FDA issued a Form 483 with 2 observations to Infusion Partners in Sharpsburg, Pennsylvania (FEI 3011127887) after an inspection that ran Sep 25, 2018. The investigator was Marcus A. Ray. Most observations concern production; the most-cited regulation is 21 CFR 211.28 (personnel responsibilities).

At a glance

2 of 2 observations on this 483 concern production.

Production2

Most cited: 21 CFR 211.28 (1×) · 211.113 (1×)

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    Personnel donned gowning apparel improperly, in a way that may have caused the gowning…

  2. 02

    Disinfecting agents and cleaning pads or wipes used in the ISO 5 area [aseptic processing…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Infusion Partners?

FDA listed 2 observations on this Form 483, mostly about production. The most-cited regulation is 21 CFR 211.28 (personnel responsibilities). The opening words of each observation are shown on this page.

Who inspected Infusion Partners?

Marcus A. Ray is named on this Form 483, for the inspection of Sep 25, 2018. Each investigator has a profile showing what they cite most.

When was Infusion Partners inspected by FDA?

The inspection ran Sep 25, 2018, and the Form 483 is dated September 25, 2018.

How do I get the full Form 483 for Infusion Partners?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free